JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Prevalence of adrenal incidentaloma in patients performed thorax computed tomography for suspected COVID-19 infection
Abstract
Aims: The primary purpose of this study is to make a retrospective evaluation of adrenal incidentaloma (AI) prevalence in patients performed thorax computed tomography (TCT), along with determining whether the diagnosed AIs were assessed functionally for adrenal gland hyperfunction and to detect the rate of hyperfunctional AI.
Methods: The patients who applied to with the suspected COVID-19 and performed TCT between January 2020 and December 2021, were included in the present study. However, the patients who were followed-up due to a known adrenal mass and a malignant tumor were excluded.
Results: TCT imaging, including adrenal glands, was performed on 2580 patients. The mean age for these patients was 54±16.8. However, when the patients were separated into groups in terms of adrenal pathology (AP), the mean age for the patients with and without AP was 61.4±11 and 53.8±16.9, respectively (p<0.001). The number of patients detected with AP, AI, and adrenal hyperplasia was 68 (2.6%), 60 (88.2%), and 7 (10.3%), respectively. The mean mass diameter was 17 (11-41). Bilateral adrenal hyperplasia was not observed in any patients; however, 13 of the patients (18.1%) detected with AI and adrenal hyperplasia were evaluated functionally. Hyperfunction was not observed in any of the assessed patients.
Conclusion: The prevalence of AI found in our study was similar to other studies in the literature; however, functional evaluations of AIs detected via TCT performed due to suspected COVID-19 remained low. Although they are rare, it is important to define whether AIs are functional or malignant due to the comorbid conditions they create. For this reason, we believe patients with AI should be directed to an endocrinology clinic for a practical examination and follow-up plan.

Keywords : Adrenal incidentaloma, adrenal hyperplasia, COVID-19, prevalence

Download Article


1. Young WF. Clinical practice. The incidentally discovered adrenalmass. N Engl J Med. 2007;356(6):601-610.
2. Wickramarachchi BN, Meyer-Rochow GY, McAnulty K, ConaglenJV, Elston MS. Adherence to adrenal incidentaloma guidelines isinfluenced by radiology report recommendations. ANZ J Surg.2016;86(6):483-486.
3. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalenceand natural history of adrenal incidentalomas. Eur J Endocrinol.2003;149(4):273-285.
4. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenalincidentaloma in a contemporary computerized tomographyseries. J Endocrinol Invest. 2006;29(4):298-302.
5. Davenport C, Liew A, Doherty B, et al. The prevalence of adrenalincidentaloma in routine clinical practice. Endocrine. 2011;40(1):80-83.
6. NIH state-of-the-science statement on management of theclinically inapparent adrenal mass (&ldquo;incidentaloma&rdquo;). NIHConsens State Sci Statements. 2002;19(2):1-25.
7. Sherlock M, Scarsbrook A, Abbas A, et al. Adrenal incidentaloma.Endocr Rev. 2020;41:008.
8. Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL.Nonfunctioning adrenal masses: incidental discovery oncomputed tomography. AJR Am J Roentgenol. 1982;139(1):81-85.
9. Taya M, Paroder V, Bellin E, Haramati LB. The relationshipbetween adrenal incidentalomas and mortality risk. Eur Radiol.2019;29(11):6245-6255.
10. Maher DI, Williams E, Grodski S, Serpell JW, Lee JC. Adrenalincidentaloma follow-up is influenced by patient, radiologic,and medical provider factors: A review of 804 cases. Surgery.2018;164(6):1360-1365.
11. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenalmass on CT: prevalence of adrenal disease in 1,049 consecutiveadrenal masses in patients with no known malignancy. AJR Am JRoentgenol. 2008;190(5):1163-1168.
12. Hammarstedt L, Muth A, W&auml;ngberg B, et al. Adrenal lesionfrequency: A prospective, cross-sectional CT study in a definedregion, including systematic re-evaluation. Acta Radiol. 2010;51(10):1149-1156.
13. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenalincidentaloma in Italy. Study Group on Adrenal Tumors ofthe Italian Society of Endocrinology. J Clin Endocrinol Metab.2000;85(2):637-644.
14. Kasperlik-Zaluska AA, Otto M, Cichocki A, et al. Incidentallydiscovered adrenal tumors: a lesson from observation of 1,444patients. Horm Metab Res. 2008;40(5):338-341.
15. Reimondo G, Castellano E, Grosso M, et al. Adrenal incidentalomasare tied to increased risk of diabetes: findings from a prospectivestudy. J Clin Endocrinol Metab. 2020;105(4):dgz284.
16. Hong AR, Kim JH, Park KS, et al. Optimal follow-up strategiesfor adrenal incidentalomas: reappraisal of the 2016 ESE-ENSATguidelines in real clinical practice. Eur J Endocrinol. 2017;177(6):475-483.
17. Ahn SH, Kim JH, Baek SH, et al. Characteristics of adrenalincidentalomas in a large, prospective computed tomography-based multicenter study: the COAR study in Korea. Yonsei MedJ. 2018;59(4):501-510.
18. Akkuş G, Evran M, Sert M, Ok F, Tetiker T. Multidisciplinaryapproach for patients with functional and non-functional adrenalmasses and review of the literature. Health Sci Rep. 2018;1(3):e22.
19. Sangwaiya MJ, Boland GWL, Cronin CG, Blake MA, Halpern EF,Hahn PF. Incidental adrenal lesions: accuracy of characterizationwith contrast-enhanced washout multidetector CT--10-minutedelayed imaging protocol revisited in a large patient cohort.Radiology. 2010;256(2):504-510.
20. Cawood TJ, Hunt PJ, O&rsquo;Shea D, Cole D, Soule S. Recommendedevaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to therisk of the adrenal lesion becoming malignant; time for a rethink?Eur J Endocrinol. 2009;161(4):513-527.
21. Comlekci A, Yener S, Ertilav S, et al.Adrenal incidentaloma,clinical, metabolic, follow-up aspects: single centre experience.Endocrine. 2010;37(1):40-46.
22. Davenport E, Lang Ping Nam P, Wilson M, Reid A, Aspinall S.Adrenal incidentalomas: management in British district generalhospitals. Postgrad Med J. 2014;90(1065):365-369.
Article available in :
Volume 6, Issue 5, 2023
Page : 1105-1108
https://doi.org/10.32322/jhsm.1327229
Article Information
Received : 14 Tem 2023
Accepted : 15 Eyl 2023
Published : 28 Eyl 2023
Corresponding Author :

Pınar Akhanlı: Department of Endocrinology and Metabolism, Dışkapı Yıldırım Beyazıt Training and Research Hospital, University of Health Sciences, Ankara, Turkey

[email protected]
Citation : Akhanlı P, Hepşen S, Kayhan S, Doğan Ö, Düzköprü Y, Çakal E. Prevalence of adrenal incidentaloma in patients performed thorax computed tomography for suspected COVID-19 infection. J Health Sci Med. 2023;6(5):1105-1108.

Read: 183
Cited: 0
Download : 176
_Footer